Dr. Tejinder P. Kaur, MD
- Medicare services, 2024
- 32,018
- Medicare patients, 2024
- 406
- Part D claims, 2024
- 1,300
- Publications
- 90
- MIPS score, 2024
- 97
- Practice address
- 5810 W Beverly Ln, Glendale, AZ 85306
- Practice phone
- Call (480) 821-2838
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Ironwood Cancer & Research Centers
Glendale, Arizona
Find Dr. Kaur's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tejinder P. Kaur is a medical oncologist in Glendale, Arizona
Dr. Kaur practices at Ironwood Cancer & Research Centers in Glendale, Arizona.
Dr. Kaur's NPI, 1649210816, was assigned on June 7, 2006. Dr. Kaur holds Arizona license 25447.
- NPI
- 1649210816NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1759396724
- NPI enumeration date
- June 7, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (480) 821-2838
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 68
- Medical school graduation
- 1984
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tejinder P. Kaur practices at Ironwood Cancer & Research Centers in Glendale, Arizona
Dr. Kaur's primary practice is Ironwood Cancer & Research Centers, at 5810 W Beverly Ln, Glendale, AZ 85306 in Maricopa County. The practice phone is (480) 821-2838.
- Ironwood Cancer & Research Centers5810 W Beverly Ln, Glendale, AZ 85306 · Maricopa CountyPhone(480) 821-2838
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Tejinder P. Kaur is affiliated with 5 sites of care and 1 medical group
Dr. Kaur's primary practice is Ironwood Cancer & Research Centers in Glendale, Arizona. Dr. Kaur is also affiliated with Banner Del E Webb Medical Center. The medical group on file is Ironwood Cancer & Research Centers. Dmand AI also links Dr. Kaur to 2 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Tejinder P. Kaur's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ironwood Cancer & Research Centers | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tejinder P. Kaur is one of 60 medical oncologists in Arizona
Medical oncology is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kaur is licensed in Arizona.
Specialties and state licenses
- Medical oncology, ArizonaPrimary
Medical oncologists near Dr. Kaur
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tejinder P. Kaur billed Medicare for 32,018 services in 2024
CMS data shows 32,018 Medicare services from Dr. Kaur across 25 procedure codes in 2024, for 406 Medicare patients. Medicare paid $205,326 for them. Every service was in an office.
Dr. Kaur's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 1,0532024: 24,4522222%
- Other services
- 2023: 4,5502024: 6,03233%
- Office and hospital visits
- 2023: 8532024: 93710%
- Tests and treatments
- 2023: 3702024: 4029%
- Imaging
- 2023: 1102024: 18165%
- Lab and pathology
- 2023: 02024: 14
Dr. Kaur compared with the Arizona median for medical oncologists, 2024
- Dr. Kaur
- Arizona median
- Medicare services
- 32,018vs 89435.8 times
- Medicare patients
- 406vs 35016% above
- Part D claims
- 1,075vs 58783% above
Medians across 62 medical oncologists in Arizona with Dmand AI profiles that report each measure.
Dr. Kaur's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kaur?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kaur and other medical oncologists in Arizona.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Tejinder P. Kaur treated 406 Medicare patients in 2024, average age 77
CMS counts 406 Medicare patients who saw Dr. Kaur in 2024. The largest group is 75 to 84, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 73, with 60% women.
Dr. Kaur's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Kaur's Medicare patients by sex, 2024
- Women24059%
- Men16641%
Chronic conditions among Dr. Kaur's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis54%
- Cancer49%
- Chronic kidney disease39%
- Ischemic heart disease34%
- Diabetes33%
- Osteoporosis27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kaur's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women60%
- Men39%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Tejinder P. Kaur wrote 1,300 Medicare Part D claims in 2024
In 2024, Dr. Kaur wrote 1,300 Medicare Part D claims for 236 patients. 80% of them were for generic drugs. CMS names the drug for 1,075 of them, across 31 drugs with 11 or more claims each, at $906,848 in total drug cost. In 2023, CMS named 1,022 claims across 25 drugs.
Dr. Kaur's Part D claims by kind of drug, 2024
- Generic1,041 claims80%
- Brand-name259 claims20%
Dr. Kaur's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kaur's Part D claims, 2024
- Opioids5%68 of 1,300 claims
- Antibiotics3%34 of 1,300 claims
- Antipsychotics, patients 65 and over3%37 of 1,300 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0222024: 1,0755%
Drugs named by CMS: 31 in 2024, 25 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Tejinder P. Kaur scored 97 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Kaur for performance year 2024. Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaur as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Kaur's MIPS scores, performance year 2024
- 97of 100Final score
- 96of 100Quality
- 98of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tejinder P. Kaur has 90 publications on record
Dmand AI links 90 papers to Dr. Kaur, published from 2011 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Printing, Three-Dimensional, Alginates and Cytokines. Dr. Kaur has published most often in J Maxillofac Oral Surg. Dr. Kaur's most frequent co-authors are Neelum T. Aggarwal, MD, Quyen Dinh Chu, MD and Michael Coughlin, DO.
Dr. Kaur's papers by year, 2016 to 2025
Topics Dr. Kaur writes about most
- Printing, Three-Dimensional
- Alginates
- Cytokines
- Materials Testing
- Polyesters
- Antibodies, Protozoan
- Binding Sites
- Cell Differentiation
Dr. Kaur's most frequent co-authors
- Neelum T. Aggarwal, MD13 shared papers
- Quyen Dinh Chu, MD13 shared papers
- Michael Coughlin, DO13 shared papers
Recent publications by Dr. Kaur
Abdom Radiol (NY)
See who Dr. Kaur researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kaur works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tejinder P. Kaur received $19,120 in industry payments from 2016 to 2025
CMS Open Payments shows 1,032 general payments to Dr. Kaur from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,627.
General payments to Dr. Kaur by program year, 2016 to 2025
General payments to Dr. Kaur by kind, 2016 to 2025
- Food and beverage$18,41196%
- Education$7094%
Companies that paid Dr. Kaur the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Tejinder P. Kaur's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tejinder P. Kaur
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tejinder P. Kaur's NPI number?
Dr. Tejinder P. Kaur's NPI number is 1649210816. It was assigned on June 7, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Tejinder P. Kaur?
Dr. Tejinder P. Kaur is a medical oncologist in Glendale, Arizona. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Tejinder P. Kaur practice?
Dr. Kaur practices at 5810 W Beverly Ln, Glendale, AZ 85306. Dr. Kaur's primary practice is Ironwood Cancer & Research Centers in Glendale, Arizona. Dmand AI also links Dr. Kaur to 2 hospitals and 1 group practice or clinic.
What is Dr. Tejinder P. Kaur's office phone number?
The practice phone on file for Dr. Kaur is (480) 821-2838.
What is Dr. Tejinder P. Kaur's medical license number?
Dr. Kaur holds Arizona license 25447.
Which hospitals is Dr. Tejinder P. Kaur affiliated with?
Dr. Kaur is affiliated with Banner Del E Webb Medical Center. Dmand AI links Dr. Kaur to 2 more hospitals.
What medical group is Dr. Tejinder P. Kaur part of?
Dr. Kaur is linked to Ironwood Cancer & Research Centers.
Does Dr. Tejinder P. Kaur accept Medicare?
Yes. CMS data shows Dr. Kaur billed Medicare for 32,018 services in 2024, and Dr. Kaur accepts Medicare assignment.
Does Dr. Tejinder P. Kaur offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kaur as offering telehealth services.
What is Dr. Tejinder P. Kaur's MIPS score?
Dr. Kaur's MIPS final score for performance year 2024 is 97 out of 100.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Tejinder P. Kaur see?
CMS counts 406 Medicare patients who saw Dr. Kaur in 2024, with an average age of 77.
What services does Dr. Tejinder P. Kaur bill to Medicare?
In 2024, Dr. Kaur's most billed Medicare services were injected or infused drug (J1439), medicare temporary code (Q9967) and injected or infused drug (J1100).
What drugs does Dr. Tejinder P. Kaur prescribe most?
In 2024 Medicare Part D data, Dr. Kaur's most prescribed drugs by claims were Anastrozole, Letrozole and Prochlorperazine Maleate.
Has Dr. Tejinder P. Kaur received payments from drug or device companies?
CMS Open Payments shows $19,120 in general payments to Dr. Kaur from 73 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Tejinder P. Kaur been practicing?
Dr. Kaur graduated from medical school in 1984, 42 years ago.
Does Dr. Tejinder P. Kaur do research?
Dmand AI links 90 publications to Dr. Kaur, published from 2011 to 2025.
Who does Dr. Tejinder P. Kaur publish with?
Dr. Kaur's most frequent co-authors are Neelum T. Aggarwal, MD (13 shared papers), Quyen Dinh Chu, MD (13 shared papers) and Michael Coughlin, DO (13 shared papers).
Selling to medical oncology practices?
See medical oncologists in Arizona by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card